Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
New role strengthens Quantori’s global leadership position in data science & digital IT
The covid health center will be managed and administered by the district administration of Ballari
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals
Go-ahead for pivotal clinical trial which is expected to commence by March
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
Phase 1/2 trial of E-602 expected to open in Q1 2022 in patients with solid tumours
Subscribe To Our Newsletter & Stay Updated
